ACSL4 and neoplasm: Tumor heterogeneity leads to significant differences in the sensitivity of different cancer types to ferroptosis: gastric cancer is resistant due to low ACSL4 expression levels, while liver cancer is more sensitive due to high SLC7A11 expression levels.